Big pharma profits

And yet it still seems to be a censorship issue when raising the factual concerns of the 'virus' financial corruption and overreaction!
 
A lot of vaccines are very cheap.

US has a policy of ludicrously high prices. Blame the voters.

Here are some example UK prices


There is an NHS tariff list somewhere.
 
Read this.


"The EU financially supported the development of the BioNTech and Pfizer vaccine and has obtained a lower price per dose ($14.70 than the US ($19.50). The Moderna vaccine’s development was subsidised by the US government, and it will cost the US about $15 a dose, while the EU is paying $18.

The Oxford-AstraZeneca vaccine is much cheaper, although neither the UK nor the US can match the EU’s $2.15 deal: they are expecting to pay about $3 and $4, respectively, per dose.

The Johnson & Johnson vaccine, expected to announce phase III results imminently, is also much cheaper, costing the EU $8.50, with each dose going twice as far as the other brands, since it is a single shot vaccine.

AstraZeneca and Johnson & Johnson have committed to not making a profit from the pandemic, while Moderna and Pfizer did not. AstraZeneca reserved the right, however, to declare the pandemic phase over and ta
 
Oxford and AstraZeneca vaccine
European Union is paying $2.15.
Per dose.
 
What does a cup of coffee cost in Costa or Starbucks?
 
Oxford and AstraZeneca vaccine
European Union is paying $2.15.
Per dose.
Now are you sure about that figure JohnD'ski???

I'm told from a source I have immense respect for that the AstraZeneca vaccine has been quietly withdrawn . . . .
 
@Dork Lard

If what your golfing buddy told you is true (who knows?)

Then they are not making anything from it any more.

Can you show us a link from a reputable source?

(Like I did)
 
Can you show us a link from a reputable source?

(Like I did)


Apparently not.
 
Thank you for helping out the dork.

"But Harnden told the Guardian that the Oxford/AstraZeneca vaccine still had an important role to play in tackling Covid worldwide, noting that the UK had donated doses to the Covax global vaccine-sharing scheme.

“[The jab] is a very effective vaccine that doesn’t have the same storage and transport issues that the mRNA vaccines have. So [it] is a very good vaccine for developing world where the temperature requirements can be more problematic,” he said. “JCVI are making recommendations on the choice of vaccines in the context of UK supply.”

Not quite what dork said.
 
Back
Top